Form 8-K - Current report:
SEC Accession No. 0001104659-06-041465
Filing Date
2006-06-13
Accepted
2006-06-13 17:07:57
Documents
4
Period of Report
2006-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-13497_28k.htm 8-K 29652
2 EX-10.1 a06-13497_2ex10d1.htm EX-10.1 72471
3 EX-99.1 a06-13497_2ex99d1.htm EX-99.1 6597
4 GRAPHIC g134972mai001.jpg GRAPHIC 12432
  Complete submission text file 0001104659-06-041465.txt   127694
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: 8-K | Act: 34 | File No.: 001-12493 | Film No.: 06902856
SIC: 2836 Biological Products, (No Diagnostic Substances)